Background: The edge-to-edge repair to correct mitral regurgitation (MR) has shown substandard results in cases of ischemic MR or dilated cardiomyopathy.
Methods: Ten porcine mitral valves were investigated in a left heart simulator (120 mm Hg, 5 L/min). Pathologic conditions of a dilated ventricle were simulated by using an annular model capable of three levels of dilation (normal, 56%, and 120%) and by displacing papillary muscles (PMs) 10 mm in the apical, lateral, and posterior directions. The edge-to-edge repair was performed; a central stitch was investigated for symmetric and asymmetric PM displacements, and a paracommissural stitch was investigated for asymmetric PM displacements. Left ventricular pressure and mitral flow rate were monitored, and regurgitation fraction was calculated from the mitral flow curve.
Results: Under symmetric PM displacement, the repair reduced MR by 5.1% at dilation level one and by 9.1% at dilation level two. The repair decreased MR by 10.9% (dilation level two) after asymmetric displacement of the anterior-lateral PM, and by 5.4% (dilation level one) and 7.9% (dilation level two) after asymmetric displacement of the posterior-medial PM. The edge-to-edge repair reduced (p < 0.05) MR owing to annular dilation; however, it was unable to completely eliminate the MR. The repair did not significantly reduce MR caused by PM displacement, regardless of the displacement geometry. Stitch location did not affect repair efficacy.
Conclusions: The edge-to-edge repair is not an effective procedure in correcting MR associated with PM displacement, although it is able to partially reduce MR caused by annular dilation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.athoracsur.2007.05.086 | DOI Listing |
Eur J Heart Fail
December 2024
Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
Catheter Cardiovasc Interv
December 2024
Heart Valve Center, San Raffaele Hospital, Milan, Italy.
Functional mitral regurgitation (MR) is associated with increased cardiovascular morbidity and mortality and over the past decade, the diagnosis of atrial functional mitral regurgitation (aFMR) has been increasingly observed in the elderly, especially in those with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). Annular enlargement, perturbations of annular contraction, and atriogenic leaflet tethering distinguish the pathophysiology of aFMR from the one of ventricular origin. However, no consensus provides recommendations regarding the differential diagnosis and the subsequent management of aFMR.
View Article and Find Full Text PDFEur Heart J Case Rep
January 2025
Department of Cardiology, Tokushima Red Cross Hospital, 103 Irinokuchi, Komatsushima, Tokushima 7730001, Japan.
J Am Heart Assoc
December 2024
Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Department of Medicine Beth Israel Deaconess Medical Center Boston MA USA.
Background: Transcatheter edge-to-edge repair of the mitral valve (mTEER) reduced a hierarchical end point that included death and heart failure hospitalization in COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation Trial). However, the magnitude to which mTEER increases the number of days a patient spends at home (DAH) in the first few years after treatment, a patient-centered end point not captured routinely in clinical trials, has not been evaluated. We compared 1- and 2-year DAH among patients with functional mitral regurgitation and heart failure randomized to mTEER plus medical therapy versus medical therapy alone (control) by linking the COAPT trial to comprehensive health care claims data.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
December 2024
Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) was initially indicated for central degenerative mitral regurgitation (DMR) lesions, but advancements in technology have enabled successful treatment in an increasing number of noncentral DMR patients.
Aims: This study aims to compare procedural outcomes and prognosis between noncentral DMR patients, outside clinical trial anatomical criteria, and central DMR patients undergoing M-TEER.
Methods: Drug-refractory moderate-to-severe DMR patients treated with M-TEER at Fuwai Hospital from January 2021 to February 2024 were retrospectively analyzed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!